Everpar Advisors LLC Lowers Position in Chemed Co. (NYSE:CHE)

Everpar Advisors LLC decreased its holdings in shares of Chemed Co. (NYSE:CHE) by 17.9% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 445 shares of the company’s stock after selling 97 shares during the period. Everpar Advisors LLC’s holdings in Chemed were worth $236,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. American National Bank & Trust bought a new stake in shares of Chemed during the 3rd quarter valued at about $61,000. GAMMA Investing LLC increased its position in shares of Chemed by 60.5% in the third quarter. GAMMA Investing LLC now owns 138 shares of the company’s stock worth $83,000 after purchasing an additional 52 shares during the last quarter. Quarry LP raised its stake in Chemed by 721.7% in the second quarter. Quarry LP now owns 189 shares of the company’s stock valued at $103,000 after purchasing an additional 166 shares in the last quarter. Sound Income Strategies LLC bought a new stake in Chemed during the third quarter valued at approximately $201,000. Finally, Farther Finance Advisors LLC grew its stake in Chemed by 2,314.3% in the 3rd quarter. Farther Finance Advisors LLC now owns 338 shares of the company’s stock worth $203,000 after buying an additional 324 shares in the last quarter. 95.85% of the stock is currently owned by hedge funds and other institutional investors.

Analyst Ratings Changes

Several analysts have recently weighed in on CHE shares. StockNews.com upgraded shares of Chemed from a “hold” rating to a “buy” rating in a research report on Saturday, November 30th. Royal Bank of Canada dropped their price target on Chemed from $697.00 to $633.00 and set an “outperform” rating for the company in a research note on Tuesday, November 5th.

Chemed Price Performance

Shares of NYSE CHE opened at $555.01 on Friday. The stock has a market capitalization of $8.35 billion, a P/E ratio of 28.04, a PEG ratio of 2.04 and a beta of 0.47. Chemed Co. has a one year low of $512.12 and a one year high of $654.62. The firm’s 50 day simple moving average is $545.31 and its two-hundred day simple moving average is $562.50.

Chemed (NYSE:CHE) last issued its earnings results on Tuesday, October 29th. The company reported $5.64 EPS for the quarter, missing analysts’ consensus estimates of $5.76 by ($0.12). The business had revenue of $606.18 million during the quarter, compared to analysts’ expectations of $612.22 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. During the same quarter in the previous year, the business earned $5.32 EPS. Chemed’s revenue for the quarter was up 7.4% compared to the same quarter last year. As a group, equities analysts expect that Chemed Co. will post 21.43 earnings per share for the current fiscal year.

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, December 6th. Stockholders of record on Monday, November 18th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. The ex-dividend date of this dividend was Monday, November 18th. Chemed’s dividend payout ratio (DPR) is presently 10.11%.

Insider Activity at Chemed

In related news, EVP Spencer S. Lee sold 732 shares of Chemed stock in a transaction on Wednesday, November 27th. The shares were sold at an average price of $575.62, for a total value of $421,353.84. Following the transaction, the executive vice president now directly owns 18,287 shares of the company’s stock, valued at $10,526,362.94. The trade was a 3.85 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the stock in a transaction on Monday, November 25th. The shares were sold at an average price of $572.77, for a total transaction of $1,145,540.00. Following the sale, the chief executive officer now directly owns 101,735 shares of the company’s stock, valued at $58,270,755.95. The trade was a 1.93 % decrease in their position. The disclosure for this sale can be found here. 3.32% of the stock is currently owned by company insiders.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.